Abu Dhabi Securities Exchange announces secondary listing of ADQ’s $2.5 billion bond

    0
    669
    Investors speak as they monitor screens displaying stock information at the Abu Dhabi Securities Exchange in this June 25, 2014 file photo. Dubai's stock index rebounds into positive territory as investors buy beaten-down property-related stocks, after the market earlier plunged as much as 5.4 percent. The index recovers to stand 1.1 percent higher at 3,987 points, bouncing back above the 200-day average at 3,866 points, which is seen as an important technical indicator. ÑREUTERS FILE

    Abu Dhabi Securities Exchange (ADX) on Thursday announced the secondary listing of the Abu Dhabi Development Holding Company’s (ADQ) $2.5 billion bond, first listed on the London Stock Exchange (LSE) in April 2024.

    The dual tranche bond, comprising a five-year $1.25 billion tranche and a ten-year $1.25 billion tranche, underscores ADX’s position as a diversified capital market and a dynamic platform for global investors.

    The bond issuance had been met with significant local and international investor demand and was oversubscribed 4.4 times.

    “ADX will continue to provide an agile and dynamic investment platform and market infrastructure to enable companies like ADQ to achieve their objectives and further Abu Dhabi’s economic diversification agenda,” said Abdulla Salem Alnuaimi, Group CEO of ADX.

    As an asset owner mandated to contribute to the sustainable development of Abu Dhabi’s economy, ADQ supports its portfolio companies in laying the foundations for future listings to optimize the funding structure and uphold best-in-class corporate governance. As of July 2024, ADQ’s portfolio encompassed eight companies listed on ADX, namely Taqa, AD Ports Group, Agthia Group, Emirates Steel Arkan, PureHealth, E7 Group, Modon Holding, and Abu Dhabi Aviation.

    With this listing, the number of debt instruments listed on ADX reaches 60.

    Source: www.khaleejtimes.com

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here